Cell Growth & Differentiation, Vol 6, Issue 1 1-8, Copyright © 1995 by American Association of Cancer Research

ARTICLES

Response of heat shock element within the human HSP70 promoter to mutated p53 genes

Y Tsutsumi-Ishii, K Tadokoro, F Hanaoka and N Tsuchida
Department of Molecular Cellular Oncology and Microbiology, Faculty of Dentistry, Tokyo Medical and Dental University, Japan.

Recent studies have demonstrated that mutation of the p53 gene caused a gain of new functions such as transforming activation, binding to heat shock cognate protein 70 and/or transactivation of a variety of promoters. In the course of seeking the biochemical basis for the gain of these functions, we have noticed the correlation between transforming activity of different mutated p53 genes and their transactivational activity on the human heat shock protein 70 promoter. Analysis of 5' deletion constructs of the heat shock protein 70 promoter showed that some specific elements within the heat shock domain containing two heat shock elements (HSEs) could respond to mutant p53 species but not basic promoter elements such as the TATA box, CCAAT box, and GC box. Subsequently, we identified the HSE as a responsive element using reporter constructs of minimal promoter containing synthetic proximal HSE, distal HSE, or GC/CCAAT box. Further analysis using in vitro mutagenesis of HSE suggests that HSE with heat shock factor binding ability is required for transactivation of the heat shock protein 70 promoter by mutated p53 genes.

This article has been cited by other articles:

				L. Weisz, A. Zalcenstein, P. Stambolsky, Y. Cohen, N. Goldfinger, M. Oren, and V. Rotter Transactivation of the EGR1 Gene Contributes to Mutant p53 Gain of Function Cancer Res., November 15, 2004; 64(22): 8318 - 8327. [Abstract] [Full Text] [PDF]

				S. Pospisilova, C. Siligan, J. Ban, G. Jug, and H. Kovar Constitutive and DNA Damage Inducible Activation of pig3 and MDM2 Genes by Tumor-Derived p53 Mutant C277Y Mol. Cancer Res., May 1, 2004; 2(5): 296 - 304. [Abstract] [Full Text] [PDF]

				J. V. Ponomarenko, T. I. Merkulova, G. V. Orlova, O. N. Fokin, E. V. Gorshkova, A. S. Frolov, V. P. Valuev, and M. P. Ponomarenko rSNP_Guide, a database system for analysis of transcription factor binding to DNA with variations: application to genome annotation Nucleic Acids Res., January 1, 2003; 31(1): 118 - 121. [Abstract] [Full Text] [PDF]

				A. Sigal and V. Rotter Oncogenic Mutations of the p53 Tumor Suppressor: The Demons of the Guardian of the Genome Cancer Res., December 1, 2000; 60(24): 6788 - 6793. [Abstract] [Full Text]

				M. Kikukawa, N. Aoki, Y. Sakamoto, and M. Mori Study of p53 in Elderly Patients with Myelodysplastic Syndromes by Immunohistochemistry and DNA Analysis Am. J. Pathol., September 1, 1999; 155(3): 717 - 721. [Abstract] [Full Text] [PDF]

				C. J. Di Como, C. Gaiddon, and C. Prives p73 Function Is Inhibited by Tumor-Derived p53 Mutants in Mammalian Cells Mol. Cell. Biol., February 1, 1999; 19(2): 1438 - 1449. [Abstract] [Full Text] [PDF]

				T. Nakajima, M. Yageta, K. Shiotsu, K. Morita, M. Suzuki, Y. Tomooka, and K. Oda Suppression of adenovirus E1A-induced apoptosis by mutated p53 is overcome by coexpression with Id proteins PNAS, September 1, 1998; 95(18): 10590 - 10595. [Abstract] [Full Text] [PDF]

				K. A. Buzzard, A. J. Giaccia, M. Killender, and R. L. Anderson Heat Shock Protein 72 Modulates Pathways of Stress-induced Apoptosis J. Biol. Chem., July 3, 1998; 273(27): 17147 - 17153. [Abstract] [Full Text] [PDF]